Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Comparison of Central Venous Port Procedures Between Puncture vs. Cut-down and Residents vs. Senior Surgeons

RYOTA OTSUBO, HIROSHI YANO, MEGUMI MATSUMOTO, AYA TANAKA, TAKASHI NONAKA, SHIGEKAZU HIDAKA, KEITARO MATSUMOTO, TOMOSHI TSUCHIYA, SHUNTARO SATO and TAKESHI NAGAYASU
In Vivo March 2021, 35 (2) 1197-1204; DOI: https://doi.org/10.21873/invivo.12369
RYOTA OTSUBO
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rotsubo{at}nagasaki-u.ac.jp
HIROSHI YANO
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MEGUMI MATSUMOTO
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYA TANAKA
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI NONAKA
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIGEKAZU HIDAKA
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEITARO MATSUMOTO
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOSHI TSUCHIYA
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUNTARO SATO
2Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI NAGAYASU
1Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: To compare operative results between venous puncture (P) with real-time ultrasonography vs. cut-down (CD) with preoperative ultrasonography for totally implantable central vein access device (TICVAD) implantation performed by residents (R) vs. senior surgeons (S). Patients and Methods: Adult oncologic patients (n=268) undergoing TICVAD implantations were retrospectively compared between 172 Ps and 96 CDs. Then, we compared Ps performed by R (P-R, n=131) and S (P-S, n=41) and CDs performed by R (CD-R, n=59) and S (CD-S, n=37). Results: Median operation times were 40 min in the P group and 53.5 min in the CD group, and times were significantly shorter for P-S and CD-S. Completion rates were comparable for each method and each surgeon. Intraoperative complication rates were 3.8% (P-R), 2.4% (P-S), and 0% (CD-R and CD-S). Conclusion: P with real-time ultrasonography did not avoid complications compared to CD with preoperative ultrasonography. The latter performed safely even by residents.

  • Punctures
  • venous cutdown
  • implantable catheters
  • residency
  • education

Owing to increased adjuvant and neoadjuvant chemotherapy, the necessity of totally implantable central vein access devices (TICVAD) has also increased. These devices are an appropriate option if long-term venous access is indicated, especially to administer cytotoxic agents or intravenous target agents in cancer patients over a long period (1). TICVADs are usually placed via the internal jugular vein or subclavian vein with the puncture (P) method, but complications accompanying central venous P, such as hemothorax, pneumothorax, and arterial injury, are critical issues (1-6). Additionally, these complications increase patients’ stress and delay treatment with chemotherapy and parenteral nutrition (7, 8). Therefore, we previously reported the usefulness of TICVADs with cut-down (CD) of the cephalic vein using preoperative ultrasonography (US) (9). Cephalic vein CD is not used frequently in clinical practice because of the technical difficulties and the wide-ranging reported incompletion rates (2.7%-20.5%) (2, 3, 10-13). Our CD method is associated with fewer complications, short operating time, and higher completion rates compared with conventional CD without preoperative US or other P methods (9).

University hospitals must educate many residents, and TICVAD implantation is typically one of the first procedures that residents learn to perform (14, 15). Because novice resident surgeons, who are in their first year as surgeons in Japan, often perform TICVAD implantation in our institution, we perform the P method via the internal jugular vein under real-time US guidance, and cephalic vein CD using preoperative US to prevent associated complications. However, it is still unclear whether these approaches are suitable for novice surgeons, and little evidence is available regarding differences between novice and experienced surgeons performing these procedures (14-16). The present study aimed to compare the operative results between the P and CD methods, and between residents and senior surgeons, regarding TICVAD implantation.

Patients and Methods

The ethics committee of our institution approved this study and the use of the details in the patients’ medical records for the study (20061519). The study met the guidelines of the Declaration of Helsinki. We retrospectively reviewed the records of 296 oncologic patients undergoing TICVAD implantation from April 2014 to December 2019 in the Department of Surgical Oncology at Nagasaki University Hospital. Because we excluded 28 patients in whom TICVAD implantations were performed by the P method via the subclavian vein, 268 oncologic patients were eligible for this study. All puncture sites for the P method were jugular veins, and all procedures for the P method were performed under real-time intraoperative US. The study group comprised 98 men and 170 women, with a median age of 64 years. The main primary diagnosis was digestive system cancer (n=92), followed by haematological malignancy (n=63), breast cancer (n=57), gynaecological cancers (n=20), lung cancer (n=19), and other tumours (n=17). A single preoperative dose of a first-generation cephalosporin was administrated in patients not receiving antibiotics. Four types of TICVADs were used: 169 (63.1%) were Safe Guide™ MicroNeedle ports with a closed-end 8.0-Fr single lumen (Cardinal Health, Dublin, OH, USA), 78 (29.1%) were PowerPort devices with a closed-end 8.0-Fr single lumen (Bard Access Systems, Salt Lake City, UT, USA), 13 (4.9%) were P-U Celsite ports with an open-end 6.0-Fr single lumen (Toray Medical Co., Ltd. Tokyo, Japan), and 8 (3.0%) were PowerPort Slims with an open-end 6.0-Fr single lumen (Bard Access Systems). The position of the distal tip of the catheter in the superior vena cava was confirmed in all patients using intraoperative fluoroscopic guidance to identify the tracheal bifurcation.

We divided patients into two groups based on the operating procedures: P method (172 procedures performed by 51 surgeons) and CD method (96 procedures performed by 21 surgeons). We also divided the patients into two additional subgroups on the basis of the surgeons’ experience for both the P and CD methods, as follows: P method performed by resident surgeons (P-R, 131 procedures performed by 32 resident surgeons), P method performed by senior surgeons (P-S, 41 procedures performed by 19 senior surgeons), CD method performed by resident surgeons (CD-R, 59 procedures performed by 15 resident surgeons), and CD method performed by senior surgeons (CD-S, 37 procedures performed by 6 senior surgeons) (Figure 1). None of the resident surgeons were board-certified surgeons, at 3 years after graduation from medical school, whereas all senior surgeons were board-certified. We compared operation time, including changing the P site and changing the procedure from CD to P, completion rate, complications, and preoperative US findings (vein diameter, depth, and convergence between the cephalic vein and axillary vein). Complications were divided into intraoperative and postoperative complications.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Flow chart of all cases. TICVADs: Totally implantable central venous access devices; P-R: Puncture method performed by resident surgeons; P-S: puncture method performed by senior surgeons; CD-R: cut-down method performed by resident surgeons; CD-S: cut-down method performed by senior surgeons.

Percutaneous puncture procedure (P-R and P-S). All puncture sites were the internal jugular veins, and real-time intraoperative US visualized the needle as it was guided through the skin and into the vein. Successful P was confirmed by venous return in the syringe. The Seldinger technique was used with a guide wire, a dilator, and a peel-away sheath for catheter insertion, and fluoroscopy was used to confirm the position of the tip of the catheter in the superior vena cava. Two incisions were necessary: a small neck incision at the catheter exit site from the skin and a second larger incision to implant the reservoir on the chest wall. A subcutaneous tunnel was made from the larger incision to the small incision in front of the clavicle, and the catheter was passed from the small incision in the neck to the larger incision in the chest wall. Next, the catheter was connected to the reservoir and placed on the major pectoral fascia. Fixation between the reservoir and the major pectoral fascia was not usually performed with the P method. Postoperative X-ray examination was performed to rule out pneumothorax and catheter kinks.

Cephalic vein cut-down procedure (CD-R and CD-S). Primary approach. Generally, when resident surgeons performed the CD procedure, a senior surgeon helped as the first assistant surgeon. After sterilizing the patient’s skin, the skin and subcutaneous layer were incised for approximately 4 cm in the upper anterior chest wall along the deltopectoral groove. The fascia between the deltoid and major pectoral muscle was cut along the muscles, and the cephalic vein was exposed then ligated distally and encircled cranially with 3-0 absorbable suture. The cephalic vein was transected, and the catheter was then inserted directly into the cephalic vein through a transverse venotomy with a vein pick. We used fluoroscopy to confirm the position of the tip of the catheter in the superior vena cava. Using the same incision, we created a subcutaneous pocket on the major pectoral fascia, and connected the catheter to the reservoir. Patency for blood retrieval and no leakage at infusion were verified by direct puncture with a Huber needle, and the reservoir was sutured to the major pectoral fascia with two absorbable sutures (Figure 2). Postoperative X-ray examination was performed to confirm the location of the catheter and reservoir.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Intraoperative images showing the cut-down approach in the right cephalic vein. A) The deltopectoral groove was exfoliated. B) The cephalic vein was encircled and cut. C) Small venotomy of the cephalic vein (arrow). D) The vein pick was inserted into the cephalic vein. E) The catheter was inserted using the vein pick. F) The connected reservoir was implanted on the major pectoral muscle.

Secondary approach. If the cephalic vein was not identified, was too small to perform CD, the catheter could not be advanced into the superior vena cava, or other reasons prevented the primary approach, the Seldinger technique was performed in the ipsilateral internal jugular vein using real-time intraoperative US. Venous access was performed using the same procedure as for P-R and P-S, and the reservoir was placed using the incision for the cephalic vein CD approach and sutured to the major pectoral fascia as for the primary approach.

Preoperative ultrasonography. When the CD approach was attempted, preoperative US was performed with an 8.0-MHz-frequency linear probe (Viamo, Toshiba Medical System, Tochigi, Japan). The cephalic vein is located in the fat below the fascia between the deltoid and the major pectoral muscle. We evaluated the cephalic vein transverse diameter and depth near the coracoid process of the scapula, and venous convergence between the cephalic and axillary vein by searching upward, to improve the completion rate (9).

Statistical analysis. We first compared data between the P and CD methods and then compared data between residents and senior surgeons for each method. Continuous data and categorical data are expressed as medians with ranges and as cases with percentages, respectively. The statistical program JMP 14 (SAS Institute, Inc., Cary, NC, USA) was used to analyze the data. Continuous data were compared using the Wilcoxon signed-rank test, and categorical data were compared using the χ2 test or Fisher’s exact test, when appropriate. Probability values <0.05 were considered statistically significant for all tests.

Results

The demographic data for each group are summarized in Table I. The median age for the CD method was significantly younger than that for the P method. Patients with digestive disease were most common in the P-R and P-S groups because the senior surgeons on the digestive disease team in our department preferred the P method, whereas patients with breast cancer predominated in the CD-R and CD-S groups because the senior surgeons on the breast and endocrine teams in our department preferred the CD method. Operation data are summarized in Table II. The median operation times were 40 min (range=21-122 min) for the P method and 53.5 min (range=28-88 min) for the CD method. For the P method, the median operation times were 42 min (range=21-122 min) in the P-R group and 33 min (range=23-82 min) in the P-S group. For the CD method, the median operation times were 57.5 min (range=33-88 min) in the CD-R group and 48 min (range=28-68 min) in the CD-S group. The operation time for the CD method was significantly longer than for the P method, and the operation times in the P-S and CD-S groups were significantly shorter than in the P-R and CD-R groups (p<0.001). Completion rates for the primary approach were 93.6% for the P method and 92.7% for the CD method. Completion rates for the primary approach were 93.1% in the P-R group and 95.1% in the P-S group, with no significant difference between the subgroups for the P method. Completion rates for the primary approach were 91.5% in the CD-R group and 94.6% in the CD-S group, with no significant difference between the subgroups for the CD method. Lack of success with the P method was related to puncture failure (n=6), arterial puncture (n=3), and failure to advance the catheter into the central vein (n=2), with no significant difference between the subgroups for the P method. Lack of success with the CD method was related to failure to advance the catheter into the central vein (n=3) and failure to cannulate the catheter into the cephalic vein (n=4), with no significant difference between the subgroups for the CD method.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Comparison of patients’ characteristics in the four groups undergoing TICVAD implantation.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Operation data for the four groups of patients undergoing TICVAD implantation.

Eighty-nine implantations were successful, and seven failed using the CD method. The venous diameter (p=0.005) and venous convergence (p=0.013) significantly affected the rate of successful implantation, after univariate analysis. Multivariate logistic regression analysis was not performed because there were too few failed cases (Table III). Adopting 3.0 mm as a cut-off value for the venous diameter in the preoperative US, the completion rate during the primary approach with venous diameters >3.0 mm was 100% (64/64), whereas the completion rate with diameters ≤3.0 mm was 81.3% (26/32).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Comparison of the variables between successful and failed TICVAD implantations in the CD group.

Seven intraoperative complications were observed for the P method, namely, six arterial punctures (3.5%) and one pneumothorax (0.6%). One arterial puncture (2.4%) occurred in the P-S group. There were no intraoperative complications for the CD method. Regarding postoperative complications, there were 22 postoperative complications for the P method, namely, 9 infections (5.2%), 2 catheter breakages (1.2%), 1 catheter obstruction (0.6%), and 2 cases of the reservoir twisting secondary to rotation (1.2%). There were two postoperative complications in the P-S group, namely, one infection (2.4%) and one thrombus (2.4%). There was no significant difference between the subgroups for the P method regarding intraoperative and postoperative complications. There were six postoperative complications for the CD method, namely, three infections (3.1%) and three twisted reservoirs (3.1%). There was no significant difference between the subgroups for the CD method regarding intraoperative and postoperative complications. There was also no significant difference between the methods regarding the total complications (Table IV).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Intraoperative and postoperative complications in the four groups of patients undergoing TICVAD implantation.

Discussion

In this study, we performed 268 TICVAD implantations, and we retrospectively divided patients into two groups based on the implantation method and subsequently divided each group into two subgroups on the basis of the surgical experience of the operators. To avoid major complications and improve the completion rate, we performed the P method using real-time US and the CD method using preoperative US (9). Although the operation time in the CD-R group was significantly longer compared with the other groups, there was no difference in the intraoperative and postoperative complication rates between the CD-R and CD-S groups. Regarding the completion rate, there was no significant difference between the CD and P method. Larger venous diameter, especially diameters >3.0 mm, and venous convergence confirmed with preoperative US contributed to successful procedures using the CD method. Although five arterial punctures and one pneumothorax occurred in the P-R group, and one arterial puncture occurred in the P-S group, even with intraoperative US, there were no intraoperative fatal complications in the CD-R and CD-S groups.

In a previous retrospective study, CD procedures for TICVAD using preoperative US were compared between procedures performed by resident surgeons 3-5 years after graduation without board certification and senior surgeons with board certification (15). Operation time and the complication rate were equivalent between the resident and senior surgeons. Moreover, the completion rate was significantly higher in the resident surgeon group, and preoperative US enabled avoiding a patient’s difficult side and contributed to a high completion rate. We also used preoperative US to evaluate whether the cephalic vein was suitable for CD, especially regarding venous convergence between the cephalic and axillary vein, which also contributed to the high completion rate for CD and relieved stress for both patients and surgeons.

Pneumothorax and haemothorax after TICVAD implantation, reported at a rate of 0.5%-6% (5, 6), are typical complications secondary to incorrect venous puncture. In our study, CD was associated with a much lower risk of these major complications. We encountered no intraoperative complications in the CD-R group because all CD procedures were performed with the assistance of a senior surgeon. Other studies have also reported no significant difference in intraoperative and postoperative complication rates when comparing TICVAD implantations performed by residents with the help of attending surgeons, with approximately 80% of TICVAD implantations performed using the CD method (16). In our institution, we require complete skeletonization of the cephalic vein during the CD procedure (Figure 2) performed by resident surgeons, to ensure venotomy and catheter insertion, and we consider that the CD procedure is a good opportunity for resident surgeons to learn basic surgical skills. However, CD performed by our resident surgeons required a longer operation time compared with senior surgeons performing either CD or P procedures. A prospective randomized trial (PORTAS-3-Trial) compared 583 patients undergoing TICVAD implantation using the CD method vs. 576 patients using the P method. The trial showed that the rate of critical complications, such as pneumothorax and haemothorax, was significantly lower with the CD method, and operation time was also shorter for the P method. Primary success rates, tolerability, morbidity, radiation dose, and 30-day mortality did not differ significantly between CD and P methods (17). Therefore, CD should be included in the reference standard for TICVAD implantation.

In this study, five patients developed a twisted reservoir as a postoperative complication: one patient (1.7%) in the CD-R group and two patients (5.4%) in the CD-S group; therefore, rates were higher than with the P method. Twisting is more likely if the reservoir is not sutured to the fascia (18). However, our conventional CD procedure involves placing two absorbable sutures in the fascia, which requires more subcutaneous space to suture firmly. Because we suspected that an excessively large subcutaneous pocket for suturing to the fascia may have led to reservoir twisting in the subcutaneous pocket, we now create a narrower, 2-cm width subcutaneous pocket, to prevent reservoir twisting without suturing to the fascia.

The first limitation of this study is its retrospective design, which meant that selection bias related to patients’ backgrounds and the type of procedure could not be eliminated. The second limitation of this study is the small overall sample size and the different sample sizes in the four groups, especially in the P-S and CD-S groups, which was related to the fact that senior surgeons rarely perform TICVAD implantations, in our institution.

In conclusion, the P method did not prevent related complications when performed by resident vs. senior surgeons using real-time US guidance; however, the CD method was performed safely even by resident surgeons because the procedure is performed under the direct supervision of the assistant senior surgeon. In addition, we improved the completion rate by confirming sufficient venous diameter and convergence between the cephalic and axillary veins, using preoperative US.

Acknowledgements

The Authors thank Jane Charbonneau, DVM, from Edanz Group (https://en-author-services.edanz.com/ac) for editing a draft of this manuscript.

Footnotes

  • Authors’ Contributions

    RO and TN were responsible for the study concept. SS was responsible for statistical analysis. All authors except for SS collaborated in the patients’ medical procedure. All Authors approved the final manuscript for submission and agreed to be accountable for the work.

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors have no conflicts of interest to declare in relation to this study.

  • Received December 29, 2020.
  • Revision received January 12, 2021.
  • Accepted January 13, 2021.
  • Copyright © 2021 The Author(s). Published by the International Institute of Anticancer Research.

References

  1. ↵
    1. Kock HJ,
    2. Pietsch M,
    3. Krause U,
    4. Wilke H and
    5. Eigler FW
    : Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 22(10): 12-16, 1998. PMID: 9465755.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Biffi R,
    2. Orsi F,
    3. Pozzi S,
    4. Pace U,
    5. Bonomo G,
    6. Monfardini L,
    7. Della Vigna P,
    8. Rotmensz N,
    9. Radice D,
    10. Zampino MG,
    11. Fazio N,
    12. de Braud F,
    13. Andreoni B and
    14. Goldhirsch A
    : Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol 20(5): 935-940, 2009. PMID: 19179550. DOI: 10.1093/annonc/mdn701
    OpenUrlCrossRefPubMed
  3. ↵
    1. Granziera E,
    2. Scarpa M,
    3. Ciccarese A,
    4. Filip B,
    5. Cagol M,
    6. Manfredi V,
    7. Alfieri R,
    8. Celentano C,
    9. Cappellato S,
    10. Castoro C and
    11. Meroni M
    : Totally implantable venous access devices: Retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution. BMC Surg 14: 27, 2014. PMID: 24886342. DOI: 10.1186/1471-2482-14-27
    OpenUrlCrossRefPubMed
    1. Klaiber U,
    2. Grummich K,
    3. Jensen K,
    4. Saure D,
    5. Contin P,
    6. Hüttner FJ,
    7. Diener MK and
    8. Knebel P
    : Closed cannulation of subclavian vein vs. open cut-down of cephalic vein for totally implantable venous access port (TIVAP) implantation: Protocol for a systematic review and proportional meta-analysis of perioperative and postoperative complications. Syst Rev 4: 53, 2015. PMID: 25896394. DOI: 10.1186/s13643-015-0043-1
    OpenUrlCrossRef
  4. ↵
    1. Shiono M,
    2. Takahashi S,
    3. Takahashi M,
    4. Yamaguchi T and
    5. Ishioka C
    : Current situation regarding central venous port implantation procedures and complications: a questionnaire-based survey of 11,693 implantations in Japan. Int J Clin Oncol 21(6): 1172-1182, 2016. PMID: 27324107. DOI: 10.1007/s10147-016-1003-z
    OpenUrlCrossRef
  5. ↵
    1. Orci LA,
    2. Meier RPH,
    3. Morel P,
    4. Staszewicz W and
    5. Toso C
    : Systematic review and meta-analysis of percutaneous subclavian vein puncture versus surgical venous cutdown for the insertion of a totally implantable venous access device. Br J Surg 101(2): 8-16, 2014. PMID: 24276950. DOI: 10.1002/bjs.9276
    OpenUrlCrossRef
  6. ↵
    1. Kakkos A,
    2. Bresson L,
    3. Hudry D,
    4. Cousin S,
    5. Lervat C,
    6. Bogart E,
    7. Meurant JP,
    8. El Bedoui S,
    9. Decanter G,
    10. Hannebicque K,
    11. Regis C,
    12. Hamdani A,
    13. Penel N,
    14. Tresch-Bruneel E and
    15. Narducci F
    : Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients. Eur J Surg Oncol 43(4): 689-695, 2017. PMID: 27889197. DOI: 10.1016/j.ejso.2016.10.020
    OpenUrlCrossRef
  7. ↵
    1. Tsutsumi S,
    2. Fukasawa T,
    3. Fujii T,
    4. Tabe Y,
    5. Kigure W,
    6. Asao T and
    7. Kuwano H
    : Central venous port system-related complications in outpatient chemotherapy for colorectal cancer. Hepatogastroenterology 59(116): 1079-1080, 2012. PMID: 22580658. DOI: 10.5754/hge09283
    OpenUrlCrossRefPubMed
  8. ↵
    1. Otsubo R,
    2. Hatachi T,
    3. Shibata K,
    4. Yoshida T,
    5. Watanabe H,
    6. Oikawa M,
    7. Matsumoto M,
    8. Yano H,
    9. Taniguchi H and
    10. Nagayasu T
    : Evaluation of totally implantable central venous access devices with the cephalic vein cut-down approach: Usefulness of preoperative ultrasonography. J Surg Oncol 113(1): 114-119, 2016. PMID: 26645575. DOI: 10.1002/jso.24100
    OpenUrlCrossRef
  9. ↵
    1. Cavallaro G,
    2. Sanguinetti A,
    3. Iorio O,
    4. D’Ermo G,
    5. Polistena N,
    6. Avenia N,
    7. Silecchia G and
    8. De Toma G
    : Ultrasound-guided vein puncture versus surgical cut-down technique in totally implantable venous access devices (Tivads): A prospective comparative study on safety, efficacy and complications. Int Surg 99(4): 475-478, 2014. PMID: 25058787. DOI: 10.9738/INTSURG-D-14-00008.1
    OpenUrlCrossRef
    1. Jablon LK,
    2. Ugolini KR and
    3. Nahmias NC
    : Cephalic vein cut-down verses percutaneous access: a retrospective study of complications of implantable venous access devices. Am J Surg 192(1): 63-67, 2006. PMID: 16769277. DOI: 10.1016/j.amjsurg.2005.11.012
    OpenUrlCrossRefPubMed
    1. Chang HM,
    2. Hsieh CB,
    3. Hsieh HF,
    4. Chen TW,
    5. Chen CJ,
    6. Chan DC,
    7. Yu JC,
    8. Liu YC and
    9. Shen KL
    : An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases. Eur J Surg Oncol 32(1): 90-93, 2006. PMID: 16289481. DOI: 10.1016/j.ejso.2005.09.004
    OpenUrlCrossRefPubMed
  10. ↵
    1. Seiler CM,
    2. Frohlich BE,
    3. Dorsam UJ,
    4. Kienle P,
    5. Buchler MW and
    6. Knaebel HP
    : Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients. J Surg Oncol 93(1): 24-29, 2006. PMID: 16353193. DOI: 10.1002/jso.20410
    OpenUrlCrossRefPubMed
  11. ↵
    1. Matsushima H,
    2. Adachi T,
    3. Iwata T,
    4. Hamada T,
    5. Moriuchi H,
    6. Yamashita M,
    7. Kitajima T,
    8. Okubo H and
    9. Eguchi S
    : Analysis of the outcomes in central venous access port implantation performed by residents via the internal jugular vein and subclavian vein. J Surg Educ 74(3): 443-449, 2017. PMID: 27932306. DOI: 10.1016/j.jsurg.2016.11.005
    OpenUrlCrossRef
  12. ↵
    1. Hashimoto S,
    2. Otsubo R,
    3. Adachi M,
    4. Doi R,
    5. Shibata K,
    6. Sano I,
    7. Shibata Y,
    8. Nakazaki T,
    9. Taniguchi H and
    10. Nagayasu T
    : Cephalic vein cut-down for totally implantable central venous access devices with preoperative ultrasonography by surgical residents. In Vivo 33(6): 2079-2085, 2019. PMID: 31662541. DOI: 10.21873/invivo.11707
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Schreckenbach T,
    2. Münch I,
    3. El Youzouri H,
    4. Bechstein WO and
    5. Habbe N
    : The safety level of total central venous access port implantation performed by residents. J Surg Educ 76(1): 182-192, 2019. PMID: 30120065. DOI: 10.1016/j.jsurg.2018.07.005
    OpenUrlCrossRef
  14. ↵
    1. Hüttner FJ,
    2. Bruckner T,
    3. Hackbusch M,
    4. Weitz J,
    5. Bork U,
    6. Kotschenreuther P,
    7. Heupel O,
    8. Kümmel S,
    9. Schlitt HJ,
    10. Mattulat M,
    11. Pintér L,
    12. Seiler CM,
    13. Gutt CN,
    14. Nottberg HS,
    15. Pohl A,
    16. Ghanem F,
    17. Meyer T,
    18. Imdahl A,
    19. Neudecker J,
    20. Müller VA,
    21. Gehrig T,
    22. Reineke M,
    23. von Frankenberg M,
    24. Schumacher G,
    25. Hennes R,
    26. Mihaljevic AL,
    27. Rossion I,
    28. Klose C,
    29. Kieser M,
    30. Büchler MW,
    31. Diener MK and
    32. Knebel P
    : Primary open versus closed implantation strategy for totally implantable venous access ports: The Multicentre Randomized Controlled PORTAS-3 Trial (DRKS 00004900). Ann Surg 272(6): 950-960, 2019. PMID: 31800490. DOI: 10.1097/SLA.0000000000003705
    OpenUrlCrossRef
  15. ↵
    1. Machat S,
    2. Eisenhuber E,
    3. Pfarl G,
    4. Stübler J,
    5. Koeblinger C,
    6. Zacherl J and
    7. Schima W
    : Complications of central venous port systems: a pictorial review. Insights Imaging 10(1): 86, 2019. PMID: 31463643. DOI: 10.1186/s13244-019-0770-2
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

In Vivo
Vol. 35, Issue 2
March-April 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Central Venous Port Procedures Between Puncture vs. Cut-down and Residents vs. Senior Surgeons
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Comparison of Central Venous Port Procedures Between Puncture vs. Cut-down and Residents vs. Senior Surgeons
RYOTA OTSUBO, HIROSHI YANO, MEGUMI MATSUMOTO, AYA TANAKA, TAKASHI NONAKA, SHIGEKAZU HIDAKA, KEITARO MATSUMOTO, TOMOSHI TSUCHIYA, SHUNTARO SATO, TAKESHI NAGAYASU
In Vivo Mar 2021, 35 (2) 1197-1204; DOI: 10.21873/invivo.12369

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Comparison of Central Venous Port Procedures Between Puncture vs. Cut-down and Residents vs. Senior Surgeons
RYOTA OTSUBO, HIROSHI YANO, MEGUMI MATSUMOTO, AYA TANAKA, TAKASHI NONAKA, SHIGEKAZU HIDAKA, KEITARO MATSUMOTO, TOMOSHI TSUCHIYA, SHUNTARO SATO, TAKESHI NAGAYASU
In Vivo Mar 2021, 35 (2) 1197-1204; DOI: 10.21873/invivo.12369
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue
  • Signal Detection Analysis of Hypnotic-induced Respiratory Depression
  • Development and Validation of an EHR-based Algorithm for Identifying Pneumocystis jirovecii Pneumonia
Show more Clinical Studies

Keywords

  • Punctures
  • venous cutdown
  • implantable catheters
  • residency
  • education
In Vivo

© 2026 In Vivo

Powered by HighWire